Indian Pacing and Electrophysiology Journal (Sep 2014)

Hemostasis of Left Atrial Appendage Bleed With Lariat Device

  • Amena Hussain, MD,
  • Muhamed Saric, MD,
  • Scott Bernstein, MD,
  • Douglas Holmes, MD,
  • Larry Chinitz, MD

Journal volume & issue
Vol. 14, no. 5
pp. 273 – 277


Read online

New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires both trans-septal puncture and epicardial access. However it requires no anticoagulation after the procedure. Here we describe a case of effusion and tamponade during a Lariat procedure with successful completion of the case and resolution of the effusion.